Trial intelligence / Profile preview

PRAISE II: Pioglitazone Effect on Neointima Volume

NCT01331967Phase 4Completed

Sponsor
Korea University Anam Hospital
Start
Feb 2011
Primary completion
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of pioglitazone in coronary artery disease (CAD), sponsored by Korea University Anam Hospital. Started Feb 2011; status: completed.

02

Drugs

pioglitazone
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT01331967.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01331967.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call